Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Pharmaceuticals
Biotech
Ex-Novartis drug clears NASH test, fueling pursuit of Akero
Boston Pharmaceuticals has posted early evidence that its ex-Novartis candidate works in nonalcoholic steatohepatitis.
Nick Paul Taylor
Jun 21, 2023 7:15am
Pieris puts phase 2 cancer drug out on chopping block
Aug 4, 2022 4:15pm
Moderna CFO Gomez departs after just one day—Chutes & Ladders
May 13, 2022 9:30am
Pieris Pharma nabs $20M upfront in Genentech collaboration
May 25, 2021 10:55am
GSK licenses early-stage cancer, CNS programs to Boston Pharma
Mar 18, 2021 7:00am
Boston raids Novartis' store again, nabbing a new NASH asset
Sep 1, 2020 8:00am